Neogenomics, Inc. · NASDAQ:NEO
Tetrault Lynn A. exercised options for 23,077 Neogenomics, Inc. shares (Form 4)
Traded Jun 1, 2026 · Filed Jun 3, 2026
On Jun 1, 2026, Tetrault Lynn A. (Director) exercised options for 23,077 Neogenomics, Inc. shares, leaving 96,729 shares. Filed Jun 3, 2026 (Form 4).
- Options exercised
- 23,077 shares
- Holding after
- 96,729 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Common Stock | Option exercise | 23,077 | 96,729 | Direct |
Source
Related
- Neogenomics, Inc.
- Tetrault Lynn A.
- Neogenomics, Inc. shareholders
- Form 4 · Tetrault Lynn A. · Jun 17, 2026
- Form 4 · Tetrault Lynn A. · Jun 11, 2026
- Form 4 · Stone Warren · Oct 5, 2026
- Form 4 · Olivo Alicia C · Sep 3, 2026
- Form 4 · Stone Warren · Aug 25, 2026
- Schedule 13G/A · First Light Asset Management, LLC · Aug 14, 2026
- Form 4 · Aunan Greg D · Aug 6, 2026